Sana Biotechnology (SANA) Change in Cash (2020 - 2026)
Sana Biotechnology recorded quarterly Change in Cash of $11.9 million in Q1 2026, up 137.89% quarter-over-quarter from -$31.5 million in Q4 2025, and up 138.39% year-over-year from $5.0 million in Q1 2025.
Sana Biotechnology's Change in Cash history runs 7 years deep, the most recent figure standing at $11.9 million for Q1 2026.
- In Q1 2026, Change in Cash rose 138.39% year-over-year to $11.9 million; the TTM figure through Mar 2026 stood at -$12.3 million (up 84.69% YoY), while the FY2025 annual figure was -$55.3 million, down 829.81% from the prior year.
- Change in Cash came in at $11.9 million for Q1 2026 at Sana Biotechnology, up from -$31.5 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $43.5 million in Q1 2024 to a low of -$64.5 million in Q1 2022.
- A 5-year average of -$10.2 million and a median of -$12.0 million in 2023 frame the typical range for Change in Cash.
- On a YoY basis, Change in Cash climbed as much as 502.99% in 2025 and fell as far as 5624.04% in 2025.
- Sana Biotechnology's Change in Cash stood at $13.4 million in 2022, then plunged by 360.25% to -$34.9 million in 2023, then surged by 101.63% to $570000.0 in 2024, then tumbled by 5624.04% to -$31.5 million in 2025, then jumped by 137.89% to $11.9 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $11.9 million, -$31.5 million, and $32.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Sana Biotechnology | 890.09 Mn | 890.09 Mn | - | 11.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.93 Mn |
| Dec 31, 2025 | -31.49 Mn |
| Sep 30, 2025 | 32.09 Mn |
| Jun 30, 2025 | -24.86 Mn |
| Mar 31, 2025 | -31.07 Mn |
| Dec 31, 2024 | 570,000.00 |
| Sep 30, 2024 | -7.96 Mn |
| Jun 30, 2024 | -42.10 Mn |
| Mar 31, 2024 | 43.54 Mn |
| Dec 31, 2023 | -34.93 Mn |
| Sep 30, 2023 | -12.02 Mn |
| Jun 30, 2023 | 13.33 Mn |
| Mar 31, 2023 | -16.31 Mn |
| Dec 31, 2022 | 13.42 Mn |
| Sep 30, 2022 | -31.32 Mn |
| Jun 30, 2022 | 7.83 Mn |
| Mar 31, 2022 | -64.51 Mn |
| Dec 31, 2021 | -180.64 Mn |
| Sep 30, 2021 | -234.79 Mn |
| Jun 30, 2021 | -75.55 Mn |
| Mar 31, 2021 | 625.88 Mn |
| Dec 31, 2020 | -24.42 Mn |
| Sep 30, 2020 | -305.82 Mn |
| Jun 30, 2020 | 365.74 Mn |
| Mar 31, 2020 | 9.64 Mn |